Peter J. Goadsby
ORCID: 0000-0003-3260-5904Also affiliated with NIHR Wellcome Trust Southampton Clinical Research Facility, King Abdullah University of Science and Technology, Wellcome Trust
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial”.
Tina M. Oakes, James M. Martinez, Bert B. Vargas, Hitendra Pandey, Eric Pearlman +5 more
Simon Akerman, Anna P. Andreou, Nazia Karsan, John A. Wemmie, Peter J. Goadsby +1 more
Lauren C. Strother, Isaac Dripps, Mohammad Rayhan Sultan Jabir, Amynah Pradhan, Peter J. Goadsby +2 more
Lauren C. Strother, Isaac Dripps, Amynah Pradhan, Peter J. Goadsby, Philip R. Holland +1 more
Peter J. Goadsby, David W. Dodick, Stewart J. Tepper, Fei Xue, Feng Zhang +3 more
Agneta Snoer, Roemer B. Brandt, Rolf Fronczek, Diana Y. Wei, Chin‐Sang Chung +22 more